Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes.
Wolf P, Winhofer Y, Krssak M, Smajis S, Harreiter J, Kosi-Trebotic L, Fürnsinn C, Anderwald CH, Baumgartner-Parzer S, Trattnig S, Luger A, Krebs M.
Wolf P, et al. Among authors: anderwald ch.
Nutr Metab Cardiovasc Dis. 2016 May;26(5):387-92. doi: 10.1016/j.numecd.2016.03.012. Epub 2016 Mar 31.
Nutr Metab Cardiovasc Dis. 2016.
PMID: 27118107
Clinical Trial.